Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study

Sara Y. Tartof(Kaiser Permanente), Jeff Slezak(Kaiser Permanente), Heidi Fischer(Kaiser Permanente), Vennis Hong(Kaiser Permanente), Bradley K. Ackerson, Omesh N. Ranasinghe(Kaiser Permanente), Timothy B. Frankland(Kaiser Permanente), Oluwaseye Ayoola Ogun(Kaiser Permanente), Joann M. Zamparo(Pfizer (United States)), Sharon Gray(Pfizer (United States)), Srinivas Rao Valluri(Pfizer (United States)), Kaije Pan(Pfizer (United States)), Frederick J. Angulo(Pfizer (United States)), Luis Jódar(Pfizer (United States)), John M. McLaughlin(Pfizer (United States))
The Lancet
October 1, 2021
Cited by 1,275Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis